Tower Research Capital LLC TRC Has $43,000 Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Tower Research Capital LLC TRC lessened its position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 85.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,275 shares of the company's stock after selling 7,433 shares during the period. Tower Research Capital LLC TRC's holdings in Tempus AI were worth $43,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. ARK Investment Management LLC lifted its position in Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after buying an additional 3,141,487 shares in the last quarter. Nikko Asset Management Americas Inc. lifted its position in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its position in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. lifted its position in Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after buying an additional 1,950,862 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after buying an additional 1,651,996 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Stock Up 9.9%

Shares of NASDAQ TEM opened at $68.91 on Wednesday. The stock has a market cap of $11.87 billion and a P/E ratio of -8.83. The firm has a 50 day moving average price of $48.99 and a 200 day moving average price of $51.30. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The business's quarterly revenue was up 75.4% compared to the same quarter last year. Analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Activity at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $52.36, for a total value of $1,047,200.00. Following the transaction, the chief operating officer now owns 884,460 shares of the company's stock, valued at approximately $46,310,325.60. The trade was a 2.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Ryan M. Bartolucci sold 6,059 shares of Tempus AI stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $80.00, for a total transaction of $484,720.00. Following the completion of the transaction, the chief accounting officer now directly owns 47,000 shares in the company, valued at approximately $3,760,000. The trade was a 11.42% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,152,613 shares of company stock worth $245,262,272. 27.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Piper Sandler reduced their price target on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 4th. Loop Capital dropped their price objective on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday, January 14th. BTIG Research started coverage on Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price objective for the company. Bank of America boosted their price objective on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. Finally, Morgan Stanley boosted their price objective on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus target price of $61.50.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.